| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-10 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-07 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.31 | 5e-06 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.31 | 1e-05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-05 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |